ArticleFrontiers in oncology2022

AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study.

Zhe Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.